Archives

by in
Entry Author Date Location
See You This Afternoon at Seattle Health IT Event 05/12/10 Seattle
How Can IT Tame the $2.5 Trillion Healthcare Beast? Xconomy Takes Close Look May 12 05/03/10 Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
Will Your Doctor Carry an iPad? Xconomy Delves Into the Future of Health IT on May 12 04/19/10 Seattle
Sage Bionetworks On a Roll, Allon’s Foray into Alzheimer’s, Frazier Bets on Antibiotics, & More Seattle-Area Life Sciences News 04/08/10 Seattle
Sage Bionetworks, UW, Fred Hutch Secure $15M Grants from State Life Sciences Fund 04/06/10 Seattle
The Dendreon Alumni Directory, Sage Snags Merck Deal, Adaptive TCR Nabs $4.5M & More Seattle-Area Life Sciences News 04/01/10 Seattle
PV Powered Bought for $90M, Adaptive TCR Raises $4.5M, Microsoft and Ford Join Forces, & More Seattle-Area Deals News 03/31/10 Seattle
Sage Bionetworks Snags Deal with Merck, Second Major Pharma Partner 03/30/10 Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News 03/18/10 Seattle
How Will Information Technology Transform Healthcare? Xconomy Seeks Answers May 12 03/17/10 Seattle
Dendreon Spending Big Bucks, Gilead Gets FDA Nod, NanoString Thinking Diagnostics, & More Seattle-Area Life Sciences News 02/25/10 Seattle
Sage Bionetworks Snaps Up $6.7M Grant to Train Young Network Biologists 02/23/10 Seattle
Synchronicity is Not Just an Album by The Police. Nor is Serendipity Just a John Cusack movie. 02/01/10 Seattle
Top Trends for the Decade Ahead in Venture, Tech, Genomics, IP, and More Innovative Fields 01/25/10 National
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News 01/12/10 Seattle
Sage Bionetworks Strikes Deal With Pfizer to Find Cancer Drug Targets 01/11/10 Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News 01/07/10 Seattle
Five Biotechnologies That Will Fade Away This Decade 01/06/10 National
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
The Future of Search Photo Gallery 12/01/09 Seattle
Only a Few Tickets Left for Monday’s Future of Search Event 11/25/09 Seattle
Future of Search Event Nov. 30 to Draw Top Startups, VCs, and Execs to UW 11/11/09 Seattle
Evri, SEOmoz, Topsy, and Sage to Present at “Future of Search” Forum 11/05/09 Seattle
See You Tonight at Seattle Life Sciences 2029 10/19/09 Seattle
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday 10/15/09 Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News 10/08/09 Seattle
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles 10/06/09 Seattle
The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle 09/02/09 Seattle
Page 2 of 3 « previous page · next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.